Refining the clinical utility of circulating tumour DNA in metastatic bladder cancer
Refining the clinical utility of circulating tumour DNA in metastatic bladder cancer
批准号:
451909
负责人:
Wyatt Alexander W
金额:
$61.3万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-09-01 至 2025-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Bladder cancer that has spread to other organs (metastatic cancer) is generally not curable and few people survive beyond five years. Excitingly, new and emerging therapies can significantly improve life expectancy. However, while providing meaningful ben
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomic dissection of de novo metastatic prostate cancer prior to treatment
-
批准号:445330
-
项目类别:Operating Grants
-
资助金额:$53.5万
-
财政年份:2021
-
负责人:Wyatt Alexander W
-
依托单位:
Predicting therapy resistance in castration-resistant prostate cancer with circulating tumor DNA
-
批准号:371318
-
项目类别:Operating Grants
-
资助金额:$37.62万
-
财政年份:2017
-
负责人:Wyatt Alexander W
-
依托单位:
Circulating tumour DNA as a precision oncology tool for metastatic bladder cancer
-
批准号:373906
-
项目类别:Salary Programs
-
资助金额:$10.56万
-
财政年份:2017
-
负责人:Wyatt Alexander W
-
依托单位:
海外基金